{"id":54935,"date":"2025-12-02T00:50:19","date_gmt":"2025-12-02T00:50:19","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/54935\/"},"modified":"2025-12-02T00:50:19","modified_gmt":"2025-12-02T00:50:19","slug":"sodurid-saavad-tulevikus-toitu-labi-naha","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/54935\/","title":{"rendered":"s\u00f5durid saavad tulevikus toitu l\u00e4bi naha"},"content":{"rendered":"<p>PropsAid: kunsthaavadest verejooksu simulatsioonideni<\/p>\n<p><img decoding=\"async\" class=\"figure__image\" onclick=\"triggerEvent('articleImageClick', { id: 17310669, focus: 'single-image', focusIndex: '17310669' })\" onkeydown=\"if (event.key === 'Enter') {&#10;        triggerEvent('articleImageClick', { id: 17310669, focus: 'single-image', focusIndex: '17310669' })&#10;        }\" role=\"button\" tabindex=\"0\" data-focus-from=\"single-image\" data-focus-index=\"17310669\" src=\"https:\/\/www.europesays.com\/ee\/wp-content\/uploads\/2025\/12\/17310669t1hb712.jpg\" onload=\"this.parentElement.classList.remove('figure__image-loading')\" alt=\"Propsaid tamponeerimiskarp\"\/>Propsaid tamponeerimiskarp Foto: Erakogu<\/p>\n<p>PropsAid on Eesti tervisetehnoloogia ettev\u00f5te, mis valmistab meditsiini\u00f5ppeks vastupidavaid ja elutruusid vahendeid: kunsthaavu, verejooksu simulaatoreid ja kunstj\u00e4semeid. Need v\u00f5imaldavad nii meditsiinitudengitel kui ka s\u00f5duritel harjutada ohtlikke olukordi v\u00f5imalikult reaalselt. Kui seni on \u00f5ppustel sageli kasutuses mannekeenid, mis ei meenuta p\u00e4ris inimest, siis PropsAid pakub m\u00e4rksa realistlikumat kogemust, aidates v\u00e4hendada kriitilistes olukordades tehtavaid vigu.<\/p>\n<p>\u00abPropsAid s\u00fcndis filmieriefektidest, mille kaudu p\u00f6\u00f6rdus meie poole Tartu Tervishoiu K\u00f5rgkool sooviga saada elutruid \u00f5ppevahendeid. Peale seda n\u00e4gime \u00fcha uuesti, kuidas tulevased meditsiinit\u00f6\u00f6tajad harjutasid vahenditega, mis ei andnud reaalse naha tunnetust. Hakkasime protot\u00fc\u00fcpima erinevaid vahendeid, mis \u00fchendaks filmiliku realismi meditsiinilise t\u00f6\u00f6kindlusega,\u00bb selgitas iduettev\u00f5tte tegevjuht Helen Maidre.<\/p>\n<p>Priotech: nutikam ja kiirem meditsiiniv\u00e4lja\u00f5pe s\u00f5duritele<\/p>\n<p><img decoding=\"async\" class=\"figure__image\" onclick=\"triggerEvent('articleImageClick', { id: 17310664, focus: 'single-image', focusIndex: '17310664' })\" onkeydown=\"if (event.key === 'Enter') {&#10;        triggerEvent('articleImageClick', { id: 17310664, focus: 'single-image', focusIndex: '17310664' })&#10;        }\" role=\"button\" tabindex=\"0\" data-focus-from=\"single-image\" data-focus-index=\"17310664\" src=\"https:\/\/www.europesays.com\/ee\/wp-content\/uploads\/2025\/12\/17310664t1hb009.jpg\" onload=\"this.parentElement.classList.remove('figure__image-loading')\" alt=\"Priotechi asutaja Arles Berg\"\/>Priotechi asutaja Arles Berg Foto: Erakogu<\/p>\n<p>Iduettev\u00f5te Priotech digitaliseerib meditsiinikoolitusi, mis on kaitsev\u00e4es siiani sageli manuaalsed ja ajamahukad. Nende loodud rakendus v\u00f5imaldab instruktoritel ja \u00f5ppuritel l\u00e4bi viia realistlikke meditsiinistsenaariume, kiirendades oskuste omandamist ja valmisolekut. Lahendust on juba testitud Eesti Kaitsev\u00e4e iga-aastastel meditsiinidrillidel ning Priotech peab l\u00e4bir\u00e4\u00e4kimisi ka NATOga platvormi kasutamiseks 2026. aasta \u00f5ppustel. Eesm\u00e4rk on aidata s\u00f5duritel teha \u00f5igeid otsuseid siis, kui aega on kriitiliselt v\u00e4he.<\/p>\n<p>\u00abMeie kaasasutaja on tervishoiu taustaga. Oma p\u00f5hit\u00f6\u00f6 k\u00f5rvalt kiirabis t\u00f6\u00f6tas ta ka erinevate meditsiinikoolituste instruktorina. Selle k\u00e4igus m\u00e4rkas ta, kui manuaalsed ja ebaefektiivsed paljud t\u00f6\u00f6vood on. Sooviga olukorda parandada hakkas ta arendama rakendust, et meditsiinikoolitusi digitaliseerida. Nii liitusid tiimiga ka teised t\u00e4nased liikmed, kellega koos asutasime Priotech\u2019i \u2013 eesm\u00e4rgiga muuta meditsiiniline koolitus nutikamaks, kiiremaks ja t\u00f5husamaks,\u00bb s\u00f5nas Priotechi asutaja Arles Berg.<\/p>\n","protected":false},"excerpt":{"rendered":"PropsAid: kunsthaavadest verejooksu simulatsioonideni Propsaid tamponeerimiskarp Foto: Erakogu PropsAid on Eesti tervisetehnoloogia ettev\u00f5te, mis valmistab meditsiini\u00f5ppeks vastupidavaid ja&hellip;\n","protected":false},"author":2,"featured_media":54936,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[27959,26,27,37,33,35,27968,34,36,31,32,21,27969,27964,27965,27966,6836,4059,27961,28,29,19,25,27958,27963,27962,27957,27967,27960,23,24,22,20,30],"class_list":{"0":"post-54935","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-eesti","8":"tag-arles-berg","9":"tag-breaking-news","10":"tag-breakingnews","11":"tag-ee","12":"tag-eesti","13":"tag-eesti-keel","14":"tag-eesti-tervisetehnoloogia","15":"tag-estonia","16":"tag-estonian","17":"tag-featured-news","18":"tag-featurednews","19":"tag-headlines","20":"tag-health-founders-estonia","21":"tag-helen-maidre","22":"tag-iduettevote","23":"tag-iduettevotted","24":"tag-idufirma","25":"tag-idufirmad","26":"tag-inga-keldo-must","27":"tag-latest-news","28":"tag-latestnews","29":"tag-news","30":"tag-populaarseimad-lood","31":"tag-priotech","32":"tag-propsaid","33":"tag-skipeat","34":"tag-startup-estonia","35":"tag-tervisetehnoloogia","36":"tag-tiit-keldo","37":"tag-top-stories","38":"tag-topstories","39":"tag-uldised-uudised","40":"tag-uudised","41":"tag-viimased-uudised"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ee\/115647232395292856","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/54935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=54935"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/54935\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/54936"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=54935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=54935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=54935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}